Toggle navigation
Home
Search
Services
Blog
Contact
About
Multimedia Pdq Breast Cancer Statements on the Web
Goldwein, Joel W.
University of Pennsylvania, Philadelphia, PA, United States
Search grants from Joel Goldwein
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dedicated breast PET and MRI for characterization of breast cancer and its response to therapy
Mechanisms of enhanced vascular SMC growth in diabetes
Neuropharmacology of Primate Cognition
Regulation of Protein Ubiquitination
Tailoring nano- and micro-porous catalytic surfaces for microfluidic biofuel cells
Recently added grants:
HIV-Related Changes to the Central-Autonomic Network and Associated Risk for Hypertension
Neural control of breathing
Role of protein-S-glutathionylation in endothelial dysfunction and atherosclerosis
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA070497-02
Application #
2009647
Study Section
Special Emphasis Panel (SRC (16))
Project Start
1995-09-30
Project End
1997-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 1996
R03 CA
Multimedia Pdq Breast Cancer Statements on the Web
Goldwein, Joel W. / University of Pennsylvania
NIH 1995
R03 CA
Multimedia Pdq Breast Cancer Statements on the Web
Goldwein, Joel W. / University of Pennsylvania
Comments
Be the first to comment on Joel Goldwein's grant